VTM C19 Transit Tube - 50 pk

VTM C19 Transit Tube - 50 pk

215.79 215.79000000000002 USD

215.79

Add to Cart
47 available


A premium transport device for use with nucleic acid testing of 
SARS-CoV-2 specimens

Biomed Diagnostics' VTM-C19 Transit Tube is intended for on-site collection and transport to the testing laboratory of human clinical specimens containing SARS-CoV-2 — the virus that causes COVID-19 disease in humans and/or (USA only) influenza A virus.  

Intended to be inoculated with specimens collected with a nasopharyngeal (NP) or oropharyngeal (OP) synthetic fiber swab (not provided), VTM-C19 has been validated to transport SARS-CoV-2 and (USA only) influenza A viral specimen appropriately to the lab for analysis with qRT-PCR.



Specifications

Product Principle

•    VTM-C19 Transit Tubes ensures a non-replicating competent status of SARS-CoV-2 (COVID-19) and (USA only) influenza A.
•    Suppresses the growth of other bacteria and fungi that may be present in clinical samples from the human respiratory system


Simple Convenience

•    Safe transport and preservation of the specimen
•    Compatible with approved nucleic acid extraction and qRT-PCR tests


Storage

The VTM-C19 Transit Tube is based on the CDC formulation which has a shelf-life of twelve-months when stored at refrigeration temperature
(2-8°C) or at room temperature (18-25°C).


Regulatory Information:

For In Vitro Diagnostic Use.

Not available in all countries; please inquire. 

CE IVD marked for use with SARS-CoV-2 testing 

The VTM-C19 Transit Tube is available for use in the USA under the FDA guidance “Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency” (July 2020). The VTM-C19 Transit Tube has completed the Notification process. The VTM-C19 Transit Tube is available for use in the USA with FDA-cleared molecular influenza tests as described in the FDA guidance “Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency” (October 2020).4